All products sold on this website are for Research Use Only (RUO). Not for human or veterinary use. Not approved by the FDA for any therapeutic purpose.

>99% Purity | Same-Day Shipping | 24/7 Research Support | Free Shipping $200+

0
Login

Product

CP10

CJC-1295 (without DAC) + IPA

4.9

(210)

Combination of cjc-1295 and ipamorelin for research into synergistic growth hormone secretion. Research applications include investigations into combined ghrh and ghrp activation, enhanced gh release, and growth factor modulation in experimental models.
1 Bottle
$99.00
2 Bottles
$94.05 (5% off)
3+ Bottles
$91.58 (7% off)
Quantity
x

15 Apl Wed - 18 Apl Wed

Free shipping protection

Overnight shipping available

We accept

Free Shipping

On Orders over $200

100% Damage

Protection

Secure Checkout

For you Everytime you purchase

Frequently Researched Together

Products commonly paired with Retatrutide for complementary research applications

GLP3-Ret

Price range: $85.00 through $195.00

  • Metabolic Research

4.9

(363)

View Product

KLOW (TB + BPC-157 + GHK + KPV)

Original price was: $194.00.Current price is: $159.00.

  • Tissue Repair Research, Dermal Research

4.9

(417)

View Product

BPC-157 + TB-500

$109.00

  • Tissue Repair Research

4.9

(233)

View Product

MOTS-C

Price range: $49.00 through $155.00

  • Metabolic Research

4.9

(238)

View Product

Compound Informations

Chemical and structural properties

GHRH Analogue CJC-1295 (NO DAC)

GHRH Analogue

CAS Number 863288-34-0
Molecular Weight ~3,367 g/mol
Amino Acids 29
Pathway Pituitary GHRH-R
Half-life (No DAC) 30 min - 2 hours
GHRP Agonist IPAMORELIN

GHRP Agonist

CAS Number 170851-70-4
Molecular Weight 711.86 g/mol
Amino Acids 5
Pathway Ghrelin/GHS-R
Selectivity No cortisol/prolactin elevation
Why This Combination BLEND INFORMATION

Why This Combination

Synergistic GH release Dual-pathway activation Pulsatile pattern preserved
Typical ratio 1:1 by weight
Combined half-life 1-2 hours (functional)
Synergy factor ~2.7x vs single pathway
Route Subcutaneous injection

Sources & References

Peer reviewed research

IRE JOURNALS

The Mechanism of Action and Synergy of CJC-1295 and Ipamorelin Peptide Blend

2026 • Volume 9, Issue 7 Perez B, et al.

View Source
PUBMED

Growth hormone (GH)-releasing hormone-(1-29) reverses decreased GH and IGF-I levels

1992 (Ref. 2026) • Clinical Trial ID: 1379256 Endocrinology Section, NIH

View Source
PUBMED CENTRAL

Efficacy of Ipamorelin, a Ghrelin Mimetic, on Gastric and Metabolic Signaling

2026 • Mechanism of Action Study Research Repository

View Source
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pulsatile Growth Hormone Secretion and GHRH/GHRP Synergy

2026 • Comparative Meta-Analysis Technical Review

View Source
Login
0

Age Verification Required

You must be 21 years or older to access this website.

You must be 21 years or older to access this website. By continuing, you confirm that you are of legal age and are purchasing these products strictly for laboratory research purposes only. These products are not for human or veterinary use.

I confirm I am 21 years or older
I am purchasing strictly for laboratory research purposes only
I understand these products are not for human or veterinary use

By clicking "I Agree", you confirm your understanding and acceptance of our terms.